INDIVIDUALIZATION OF HIGH-DOSE METHOTREXATE POSOLOGY BY DETERMINATION OF PLASMA-CONCENTRATIONS AND ITS ROLE IN THE TREATMENT OF OSTEOGENIC-SARCOMA

被引：0
|
作者：
DELEPINE, N
DESBOIS, JC
DELEPINE, G
CORNILLE, H
ASTIER, A
ALKALLAF, S
机构：
[1] CLIN PRE GENTIL,UNITE ONCOL ORTHOPED,F-93000 ROSNY BOIS,FRANCE
[2] HOP HENRI MONDOR,SERV TOXICOL,F-94000 CRETEIL,FRANCE
来源：
BULLETIN DU CANCER | 1989年 / 76卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：913 / 918
页数：6
相关论文
共 50 条
  • [1] RESULTS OF TREATMENT OF OSTEOGENIC-SARCOMA WITH HIGH-DOSE METHOTREXATE
    PEREVODCHIKOVA, NI
    YEREMINA, LA
    MANZYUK, LV
    SINYUKOV, PA
    FEDENKO, AN
    SINGIN, AS
    MOLDOVANOVA, LK
    VOPROSY ONKOLOGII, 1990, 36 (06) : 667 - 671
  • [2] ROLE OF HIGH-DOSE METHOTREXATE WITH CITROVORUM FACTOR RESCUE IN TREATMENT OF OSTEOGENIC-SARCOMA
    JAFFE, N
    TRAGGIS, D
    CASSADY, JR
    FILLER, RM
    WATTS, H
    FREI, E
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1977, 2 (3-4): : 261 - 266
  • [3] PHARMACOKINETICS OF HIGH-DOSE METHOTREXATE IN ADULT OSTEOGENIC-SARCOMA
    PIGNON, T
    LACARELLE, B
    DUFFAUD, F
    GUILLET, P
    CATALIN, J
    DURAND, A
    MONJANEL, S
    FAVRE, R
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1994, 33 (05) : 420 - 424
  • [4] CLINICAL OBSERVATIONS ON USE OF HIGH-DOSE METHOTREXATE TREATMENT IN OSTEOGENIC-SARCOMA
    KOTZ, R
    LEBER, H
    RAMACH, W
    ARBES, H
    WOLF, A
    WIENER KLINISCHE WOCHENSCHRIFT, 1977, 89 (14) : 474 - 479
  • [5] HIGH-DOSE METHOTREXATE THERAPY IN OSTEOGENIC-SARCOMA - PLASMA PHARMAKOKINETICS TO PREDICT TOXICITY
    JANKA, GE
    WIESNER, H
    BIDLINGMAIER, F
    HAAS, RJ
    KLINISCHE WOCHENSCHRIFT, 1979, 57 (08): : 411 - 416
  • [6] HIGH-DOSE METHOTREXATE AND LEUCOVORIN RESCUE IN DOGS WITH OSTEOGENIC-SARCOMA
    COTTER, SM
    PARKER, LM
    AMERICAN JOURNAL OF VETERINARY RESEARCH, 1978, 39 (12) : 1943 - 1945
  • [7] ADJUVANT TREATMENT OF OSTEOGENIC-SARCOMA WITH HIGH-DOSE CYCLOPHOSPHAMIDE
    SHEPP, M
    NECHELES, TF
    BANKS, HH
    OH, WH
    ZIMBLER, S
    CANCER TREATMENT REPORTS, 1978, 62 (02): : 295 - 296
  • [8] HIGH-DOSE METHOTREXATE IN OSTEOGENIC-SARCOMA - 5-YEAR EXPERIENCE
    JAFFE, N
    FREI, E
    WATTS, H
    TRAGGIS, D
    CANCER TREATMENT REPORTS, 1978, 62 (02): : 259 - 264
  • [9] TRANSIENT NEUROLOGICAL DISTURBANCES INDUCED BY THE CHEMOTHERAPY OF HIGH-DOSE METHOTREXATE FOR OSTEOGENIC-SARCOMA
    KIU, MC
    LIAW, CC
    YANG, TS
    LAI, GM
    HSI, SN
    LU, CS
    ANTI-CANCER DRUGS, 1994, 5 (04) : 480 - 482
  • [10] HIGH-DOSE METHOTREXATE IN OSTEOGENIC-SARCOMA ADJUVANT CHEMOTHERAPY AND LIMB SALVAGE RESULTS
    JAFFE, N
    GOORIN, A
    LINK, M
    WATTS, H
    FREI, E
    VAWTER, G
    FELLOWS, KE
    BEARDSLEY, GP
    ABELSON, HT
    CANCER TREATMENT REPORTS, 1981, 65 : 99 - 106
12345